MedTrace Logo

A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers

NCT01118702 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2012-12-11

No results posted yet for this study

Summary

This is a study of blood plasma levels of methylphenidate in healthy volunteers over a 24 hour period after they take this medication.

Conditions

  • Pharmacokinetics

Interventions

DRUG

Ritalin-SR

3-20mg tablets, once

DRUG

Concerta

one 54mg tablet, once

DRUG

Novo-Methylphenidate ER-C

one 54mg tablet, once

Sponsors & Collaborators

  • Janssen-Ortho Inc., Canada

    lead INDUSTRY

Principal Investigators

  • Janssen-Ortho Inc. Clinical Trial · Janssen-Ortho Inc., Canada

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-05-31
Completion
2010-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01118702 on ClinicalTrials.gov